98%
921
2 minutes
20
To accurately estimate muscle forces using electromyogram (EMG) signals, precise EMG amplitude estimation, and a modeling scheme capable of coping with the nonlinearities and dynamics of the EMG-force relationship are needed. In this work, angle-based EMG amplitude calibration and parallel cascade identification (PCI) modeling are combined for EMG-based force estimation in dynamic contractions, including concentric and eccentric contractions of the biceps brachii and triceps brachii muscles. Angle-based calibration has been shown to improve surface EMG (SEMG) based force estimation during isometric contractions through minimization of the effects of joint angle related factors, and PCI modeling captures both the nonlinear and dynamic properties of the process. SEMG data recorded during constant force, constant velocity, and varying force, varying velocity flexion and extension trials are calibrated. The calibration values are obtained at specific elbow joint angles and interpolated to cover a continuous range of joint angles. The calibrated data are used in PCI models to estimate the force induced at the wrist. The experimental results show the effectiveness of the calibration scheme, combined with PCI modeling. For the constant force, constant velocity trials, minimum %RMSE of 8.3% is achieved for concentric contractions, 10.3% for eccentric contractions and 33.3% for fully dynamic contractions. Force estimation accuracy is superior in concentric contractions in comparison to eccentric contractions , which may be indicative of more nonlinearity in the eccentric SEMG-force relationship.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TNSRE.2014.2325713 | DOI Listing |
JACC Case Rep
July 2025
Department of Emergency Medicine, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA; Texas Emergency Medicine Research Center, Houston, Texas, USA.
Background: The timely transfer of patients with ST-segment elevation myocardial infarction (STEMI) to percutaneous coronary intervention-capable centers is critical for improving outcomes. Although the American Heart Association recommends a door-in-door-out (DIDO) time of ≤30 minutes, national compliance remains low.
Project Rationale: At Harris Health, no patients with STEMI met this benchmark before 2022.
Kardiologiia
September 2025
Department of Cardiology, The Ninth Medical Center, Chinese PLA General Hospital.
Background Hyperuricemia (HUA) frequently coexists with coronary artery disease (CAD) and is linked to adverse cardiovascular outcomes. The long-term impact of urate-lowering therapy (ULT) on clinical outcomes, including all-cause mortality and major adverse cardiovascular events (MACEs), in CAD patients after percutaneous coronary intervention (PCI) has not been determined. That was the aim of this study.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
Cardiovascular Surgery Department, Ankara Bilkent City Hospital, 06800 Ankara, Turkey.
Background: This study aimed to investigate the performance of two versions of ChatGPT (o1 and 4o) in making decisions about coronary revascularization and to compare the recommendations of these versions with those of a multidisciplinary Heart Team. Moreover, the study aimed to assess whether the decisions generated by ChatGPT, based on the internal knowledge base of the system and clinical guidelines, align with expert recommendations in real-world coronary artery disease management. Given the increasing prevalence and processing capabilities of large language models, such as ChatGPT, this comparison offers insights into the potential applicability of these systems in complex clinical decision-making.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
Nursing Department, The First Affiliated Hospital of Ningbo University, 315000 Ningbo, Zhejiang, China.
Background: To explore the potential categories of compliance development track of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS) using growth mixture modeling (GMM) to analyze its predictive factors, providing evidence for dynamic adherence monitoring and tailored interventions.
Methods: A total of 150 patients with ACS after PCI were selected by convenience sampling. Patients were studied using Self-Efficacy for Appropriate Medication Use Scale (SEAMS), family APGAR index (APGAR), Generalized Anxiety Disorder-2 (GAD-2), and Patient Health Questionnaire-2 (PHQ-2) at baseline.
Rev Cardiovasc Med
August 2025
Center for Coronary Heart Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China.
Background: Globally, acute myocardial infarction (AMI) is among the primary causes of mortality. The ideal approach for blood pressure (BP) management for patients experiencing ST-segment elevation myocardial infarction (STEMI) who receive percutaneous coronary intervention (PCI) remains a topic of ongoing debate. Current guidelines on BP management lack specific recommendations for STEMI patients undergoing PCI, resulting in substantial individual variability and uncertainties in clinical treatment strategies.
View Article and Find Full Text PDF